Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Medtronic launches new diabetes tech integrated with Abbott sensor
Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.
$V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.$
FDA panel votes against approving first-of-its-kind heart failure device
All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these recommendations? Only time will tell.
FDA issues warning about Olympus ligating devices after 113 injuries
The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.
Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
Interventional cardiology groups unite to push the specialty forward
SCAI and CRT have announced a new partnership focused on education, advocacy and research.

European Society of Cardiology publishes new genetic testing guidelines for heart conditions

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members.

District of Columbia DC congress capitol hill

CMS delays start of Radiation Oncology Alternative Payment Model yet again

The mandatory bundled payment initiative was slated to kick off Jan. 1, 2023, following numerous delays, but will now launch on a to-be-determined date.

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

Renal denervation linked to significant blood pressure reductions after 3 years

An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet.

AI model able to ID early signs of type 2 diabetes on imaging results

The authors hope their findings could lead to earlier diagnoses and improvements in patient care.

PCI vs. CABG for left main disease: Key takeaways from a new meta-analysis

Researchers explored data from five different randomized controlled trials, publishing their analysis in the American Journal of Cardiology.

Abbott’s Aveir single-chamber (VR) leadless pacemaker

Abbott’s single-chamber leadless pacemaker gains FDA approval

Another single-chamber leadless pacemaker has officially hit the market.

TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

Read our in-person coverage of the final day of ACC.22.

AI predicts COVID prognosis at near-expert level using CT scoring system

A deep convolutional neural network was able to predict hospital stay, ICU admission and intubation when scoring chest CT images of hospitalized COVID patients.

Clinical

Medtronic launches new diabetes tech integrated with Abbott sensor

FDA panel votes against approving first-of-its-kind heart failure device

FDA issues warning about Olympus ligating devices after 113 injuries

Patient communication AI company receives $65M in funding from private equity

Interventional cardiology groups unite to push the specialty forward